Answers are grounded in this paper and cite their sources.
// Meng Shen 1,3,4 , Qian Sun 1,3,4 , Jian Wang 1,3,4 , Wei Pan 1,3,4 and Xiubao Ren 2,3,4 1 Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China 2 Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China 3 National Clinical Research Center of Cancer, Tianjin, China 4 Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China Correspondence to: Xiubao Ren, email: // Keywords : B lymphocytes, regulatory B cells, tumor-infiltrating B cells, tumor, tumor immunotherapy Received : January 22, 2016 Accepted : June 04, 2016 Published : June 15, 2016 Abstract Accumulating evidence indicated that B lymphocytes exerted complex functions in tumor immunity. On the one hand, B lymphocytes can inhibit tumor development through antibody generation, antigen presentation, tumor tissue interaction, and direct killing. On the other hand, B lymphocytes have tumor-promoting functions. A typical type of B lymphocytes, termed regulatory B cells, is confirmed to attenuate immune response in a tumor environment. In this paper, we summarize the current understanding of B-cell functions in tumor immunology, which may shed light on potential therapeutic strategies against cancer.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: